Page 33 - Max Planck Society

Neuroscience

Possible treatment for Charcot-Marie-Tooth disease discovered

Charcot-Marie-Tooth disease is the most common hereditary neuropathy and affects more than 2 million people worldwide. Researchers at the Max-Planck-Institute for Experimental Medicine and the University Medical Center of ...

Health

Air pollution – a neglected cause of death 

In 2015, around 4.5 million people died prematurely from diseases attributed to ambient air pollution, including 237,000 children under the age of five from respiratory infections. This is the result of a study published ...

Diseases, Conditions, Syndromes

First ancient syphilis genomes decoded

An international research team, including scientists from the Max Planck Institute for the Science of Human History, the University of Tübingen, the National School of Anthropology and History in Mexico City, and the University ...

Neuroscience

Neural circuit mechanisms of emotion identified

According to a report by the World Health Organization, close to 1 in 10 people in the world are affected by anxiety and/or depression. Alarmingly, the amount has nearly doubled, from 416 million to 615 million, between 1990 ...

Diabetes

Diabetes results from a breakdown of epigenetic control

Diabetes affects more than 400 million individuals worldwide. In what is becoming a paradigm shift, researchers have begun to find that the disease may result in part through pancreatic beta cells losing their functional ...

Psychology & Psychiatry

Culture shapes the brain: How reading changes the way we think

From a research perspective, reading and writing is a fascinating phenomenon. After all, the first writing systems date back less than 6,000 years – the blink of an eye in the timescale of human evolution. How the human ...

Diseases, Conditions, Syndromes

Activity of two genes able to predict active tuberculosis

The closer the contact someone has with individuals with tuberculosis, the more likely they are to become infected with the pathogen. However, only about five to ten percent of people infected with the pathogen go on to develop ...

Diseases, Conditions, Syndromes

Candidate tuberculosis vaccine in phase II/III trial

Tuberculosis remains the most deadly infectious diseases in the world. In particular, the growing number of multiresistant microbes is a cause of great concern to doctors and healthcare policymakers. At least a dozen candidate ...

page 33 from 40